Product NDC: | 60977-016 |
Proprietary Name: | Duramorph |
Non Proprietary Name: | morphine sulfate |
Active Ingredient(s): | .5 mg/mL & nbsp; morphine sulfate |
Administration Route(s): | EPIDURAL; INTRATHECAL; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60977-016 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018565 |
Marketing Category: | NDA |
Start Marketing Date: | 20100531 |
Package NDC: | 60977-016-02 |
Package Description: | 10 AMPULE in 1 PACKAGE (60977-016-02) > 10 mL in 1 AMPULE (60977-016-73) |
NDC Code | 60977-016-02 |
Proprietary Name | Duramorph |
Package Description | 10 AMPULE in 1 PACKAGE (60977-016-02) > 10 mL in 1 AMPULE (60977-016-73) |
Product NDC | 60977-016 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | morphine sulfate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | EPIDURAL; INTRATHECAL; INTRAVENOUS |
Start Marketing Date | 20100531 |
Marketing Category Name | NDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | MORPHINE SULFATE |
Strength Number | .5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |